Local and systemic administration of AAV vectors with alphaherpesvirus latency-associated promoter 2 drives potent transgene expression in mouse liver, kidney, and skeletal muscle-Reference-Cited by-同舟云学术

Local and systemic administration of AAV vectors with alphaherpesvirus latency-associated promoter 2 drives potent transgene expression in mouse liver, kidney, and skeletal muscle

Published:2023-04 Issue: Volume:314 Page:114688
ISSN:0166-0934
Container-title:Journal of Virological Methods
language:en
Short-container-title:Journal of Virological Methods

Author:

Maturana Carola J.,Chan Angela,Verpeut Jessica L.,Engel Esteban A.

Publisher

Elsevier BV

Subject

Virology

Reference56 articles.

1. Nephron segment-specific gene expression using AAV vectors;Asico;Biochem Biophys. Res. Commun.,2018

2. Gene therapy advances: a meta-analysis of AAV usage in clinical settings;Au;Front Med. (Lausanne),2021

3. QuPath: Open source software for digital pathology image analysis;Bankhead;Sci. Rep.,2017

4. Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor;Barbon;Gene Ther.,2021

5. Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects;Baruteau;J. Inherit. Metab. Dis.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent transgene expression in peripheral tissues one year post intravenous and intramuscular administration of AAV vectors containing the alphaherpesvirus latency-associated promoter 2;Frontiers in Virology;2024-03-28

2. The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution;Medicinal Research Reviews;2024-03-28

3. Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2;BMC Cancer;2023-12-11

4. Engineered compact pan-neuronal promoter from Alphaherpesvirus LAP2 enhances target gene expression in the mouse brain and reduces tropism in the liver;Gene Therapy;2023-11-27